IBDEI0Z7 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17484,1,1,0)
 ;;=1^238.9
 ;;^UTILITY(U,$J,358.3,17484,1,8,0)
 ;;=8^Lymph/Hematopoietic Tissue NOS
 ;;^UTILITY(U,$J,358.3,17484,2)
 ;;=^267780
 ;;^UTILITY(U,$J,358.3,17485,0)
 ;;=239.0^^111^1089^5
 ;;^UTILITY(U,$J,358.3,17485,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17485,1,1,0)
 ;;=1^239.0
 ;;^UTILITY(U,$J,358.3,17485,1,8,0)
 ;;=8^Digestive Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17485,2)
 ;;=^267781
 ;;^UTILITY(U,$J,358.3,17486,0)
 ;;=239.1^^111^1089^11
 ;;^UTILITY(U,$J,358.3,17486,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17486,1,1,0)
 ;;=1^239.1
 ;;^UTILITY(U,$J,358.3,17486,1,8,0)
 ;;=8^Respiratory Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17486,2)
 ;;=^267782
 ;;^UTILITY(U,$J,358.3,17487,0)
 ;;=239.2^^111^1089^2
 ;;^UTILITY(U,$J,358.3,17487,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17487,1,1,0)
 ;;=1^239.2
 ;;^UTILITY(U,$J,358.3,17487,1,8,0)
 ;;=8^Bone,Soft Tissue,Skin Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17487,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,17488,0)
 ;;=239.3^^111^1089^4
 ;;^UTILITY(U,$J,358.3,17488,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17488,1,1,0)
 ;;=1^239.3
 ;;^UTILITY(U,$J,358.3,17488,1,8,0)
 ;;=8^Breast Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17488,2)
 ;;=^81977
 ;;^UTILITY(U,$J,358.3,17489,0)
 ;;=239.4^^111^1089^1
 ;;^UTILITY(U,$J,358.3,17489,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17489,1,1,0)
 ;;=1^239.4
 ;;^UTILITY(U,$J,358.3,17489,1,8,0)
 ;;=8^Bladder Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17489,2)
 ;;=^81975
 ;;^UTILITY(U,$J,358.3,17490,0)
 ;;=239.5^^111^1089^9
 ;;^UTILITY(U,$J,358.3,17490,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17490,1,1,0)
 ;;=1^239.5
 ;;^UTILITY(U,$J,358.3,17490,1,8,0)
 ;;=8^Oth Genitourinary Org Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17490,2)
 ;;=^267784
 ;;^UTILITY(U,$J,358.3,17491,0)
 ;;=239.6^^111^1089^3
 ;;^UTILITY(U,$J,358.3,17491,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17491,1,1,0)
 ;;=1^239.6
 ;;^UTILITY(U,$J,358.3,17491,1,8,0)
 ;;=8^Brain Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17491,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,17492,0)
 ;;=239.7^^111^1089^6
 ;;^UTILITY(U,$J,358.3,17492,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17492,1,1,0)
 ;;=1^239.7
 ;;^UTILITY(U,$J,358.3,17492,1,8,0)
 ;;=8^Endocrine/Nerv Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17492,2)
 ;;=^267785
 ;;^UTILITY(U,$J,358.3,17493,0)
 ;;=239.81^^111^1089^12
 ;;^UTILITY(U,$J,358.3,17493,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17493,1,1,0)
 ;;=1^239.81
 ;;^UTILITY(U,$J,358.3,17493,1,8,0)
 ;;=8^Retina/Choroid Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,17493,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,17494,0)
 ;;=239.89^^111^1089^7
 ;;^UTILITY(U,$J,358.3,17494,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17494,1,1,0)
 ;;=1^239.89
 ;;^UTILITY(U,$J,358.3,17494,1,8,0)
 ;;=8^Neoplasm,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,17494,2)
 ;;=^338225
 ;;^UTILITY(U,$J,358.3,17495,0)
 ;;=239.9^^111^1089^8
 ;;^UTILITY(U,$J,358.3,17495,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17495,1,1,0)
 ;;=1^239.9
 ;;^UTILITY(U,$J,358.3,17495,1,8,0)
 ;;=8^Neoplasm,Unspec Site 
 ;;^UTILITY(U,$J,358.3,17495,2)
 ;;=^82022
 ;;^UTILITY(U,$J,358.3,17496,0)
 ;;=288.9^^111^1089^15
 ;;^UTILITY(U,$J,358.3,17496,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17496,1,1,0)
 ;;=1^288.9
 ;;^UTILITY(U,$J,358.3,17496,1,8,0)
 ;;=8^Unspec Dis of WBC
 ;;^UTILITY(U,$J,358.3,17496,2)
 ;;=^267993
 ;;^UTILITY(U,$J,358.3,17497,0)
 ;;=289.0^^111^1089^13
 ;;^UTILITY(U,$J,358.3,17497,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17497,1,1,0)
 ;;=1^289.0
 ;;^UTILITY(U,$J,358.3,17497,1,8,0)
 ;;=8^Secondary Polycythemia
 ;;^UTILITY(U,$J,358.3,17497,2)
 ;;=^186856
